Effectiveness of Non-surgical Management in Rotator Cuff Calcific Tendinopathy (THE EFFECT TRIAL)

Launched by UNIVERSITY OF VALENCIA · Jul 26, 2022

Keywords

ClinConnect Summary

The EFFECT trial is a study looking at different ways to treat a condition called rotator cuff calcific tendinopathy, which causes pain and difficulty moving the shoulder due to calcium deposits in the rotator cuff. Researchers want to see how well an exercise therapy program works compared to two other treatments: extracorporeal shockwave therapy (a non-invasive treatment that uses sound waves) and ultrasound-guided irrigation (a method to wash out the calcium), as well as a "wait and see" approach.

To participate in this trial, you need to be between 18 and 80 years old and have a confirmed calcium deposit in your rotator cuff, along with shoulder pain and reduced movement. You should not be currently receiving any physiotherapy or shockwave therapy. If you join the study, you'll be assigned to one of the treatment groups and will be monitored to see how well the treatment helps with your pain and shoulder function. This trial is currently looking for volunteers, so if you're interested, it could be a good opportunity to explore treatment options for your shoulder pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • calcification deposit in the rotator cuff confirmed by diagnostic imaging (ultrasound, MRI or X-ray);
• • pain and loss of function in the shoulder;
• • not currently receiving physiotherapy or ESWT.
• Exclusion Criteria:
• • previous treatments on last year (e.g., injections, ESWT, US-PICT, surgery, etc.);
• • other shoulder disorders or trauma (e.g., fractures, dislocations, rotator cuff tears, frozen shoulder or shoulder instability);
• • known allergy to any of the pharmacological products used in the study;
• • taking oral anticoagulants
• • taking oral steroid within the six months prior to participation in the study;
• • cancer, systemic disease, pregnancy or infection;
• • neck pain.